Phlow Corp., a new Richmond-based pharmaceutical manufacturing company, has received a $354 million federal contract to help build a strategic, national reserve of essential medications and to make ac Corp., a new Richmond-based pharmaceutical manufacturing company, has received a $354 million federal contract to help build a strategic, national reserve of essential medications and to make active ingredients for more than a dozen medicines used to treat patients with COVID-19.

Load comments